Showing results (731-740 of 3,353) with videos related to
Sort By:
Pageof 336
The Lancet. Oncology|March 13, 2022
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 studyJulie Delyon, Lucie Biard, Marion Renaud, et al.The Lancet. Oncology|April 15, 2022
Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trialWalter Heindel, Stefanie Weigel, Joachim Gerß, et al.The Lancet. Oncology|July 28, 2022
Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESPMaria Kyrgiou, Antonios Athanasiou, Marc Arbyn, et al.The Lancet. Oncology|January 29, 2022
A comprehensive framework for early-onset colorectal cancer researchCathy Eng, Alexandre A Jácome, Rajiv Agarwal, et al.The Lancet. Oncology|June 18, 2018
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysisIoannis Psallidas, Nikolaos I Kanellakis, Stephen Gerry, et al.The Lancet. Oncology|December 5, 2009
Evolving novel anti-HER2 strategiesKellie L Jones, Aman U BuzdarThe Lancet. Oncology|December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialKathy S Albain, William E Barlow, Steven Shak, et al.The Lancet. Oncology|December 3, 2005
High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparisonMinoru Tanaka, Yasushi Ino, Keiichi Nakagawa, et al.The Lancet. Oncology|December 3, 2005
Tumour-cell fusion as a source of myeloid traits in cancerJohn M PawelekPageof 336